Medgend Icon







discontinued


Aprepitant FDA Approved Drugs

APREPITANT [AprepitantC23H21F7N4O3]
RX
-
125mg (oral capsule)
40mg (oral capsule)
80mg (oral capsule)
SandozSep 24, 2012
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EMEND [AprepitantC23H21F7N4O3]
RX
-
125mg (oral capsule)
125mg/kit (oral for suspension)
40mg (oral capsule)
80mg (oral capsule)
MerckMar 26, 2003
Msd Merck CoDec 17, 2015
  • For the prevention of nausea and vomiting associated with chemotherapy.
  • Prevention of post-operative nausea and vomiting.
  • Prevention of postoperative nausea and vomiting.
  • Treatment or prevention of emesis.
efficacy
2.0  (1)
side effects
4.0  (1)
danger
0.0  (0)

UNK

EMEND [Fosaprepitant DimeglumineC23H22F7N4O6P2C7H17NO5]
RX
-
eq 150mg base/vial (intravenous powder)
Merck And Co IncNov 12, 2010
efficacy
4.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FOSAPREPITANT DIMEGLUMINE [Fosaprepitant DimeglumineC23H22F7N4O6P2C7H17NO5]
RX
-
eq 150mg base/vial (intravenous powder)
Fresenius Kabi UsaJun 9, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.